Silong Zhang
Key Laboratory Of Coal Conversion And New Carbon Materials Of Hubei Province
Wuhan, 430081, China
Wuhan, 430081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Design of Sonosensitizers Integrated with Resveratrol Motif for Synergetic Sonodynamic Therapy and Nuclear Factor Kappa B Transcription Suppression of Breast Cancer.
Journal: Journal of medicinal chemistry
Published: April 19, 2023
Aridity modulates biogeographic distribution and community assembly of cyanobacterial morphotypes in drylands.
Journal: FEMS microbiology ecology
Published: April 18, 2023
Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability.
Journal: Journal of medicinal chemistry
Published: March 24, 2023
Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma.
Journal: Journal of medicinal chemistry
Published: November 17, 2022
Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma.
Journal: Journal of medicinal chemistry
Published: September 29, 2022
Targeted Recruitment and Degradation of Estrogen Receptor α by Photothermal Polydopamine Nanoparticles for Breast Tumor Ablation.
Journal: Advanced healthcare materials
Published: April 27, 2022
Cu-Doped black phosphorus quantum dots as multifunctional Fenton nanocatalyst for boosting synergistically enhanced H2O2-guided and photothermal chemodynamic cancer therapy.
Journal: Nanoscale
Published: February 21, 2022
Activable Targeted Protein Degradation Platform Based on Light-triggered Singlet Oxygen.
Journal: Journal of medicinal chemistry
Published: February 15, 2022
Construction of benzofuranone library via a metal-free, one-pot intermolecular condensation, and their application as efficient estrogen receptor β modulators.
Journal: Chemical communications (Cambridge, England)
Published: October 30, 2019
Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs).
Journal: European journal of medicinal chemistry
Published: January 15, 2019
Novel Hybrid Conjugates with Dual Suppression of Estrogenic and Inflammatory Activities Display Significantly Improved Potency against Breast Cancer.
Journal: Journal of medicinal chemistry
Published: July 29, 2018
Dual functional small molecule fluorescent probes for image-guided estrogen receptor-specific targeting coupled potent antiproliferative potency for breast cancer therapy.
Journal: Bioorganic & medicinal chemistry
Published: February 20, 2017
Last Updated: 09/26/2026